Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.59 USD
−3.34 M USD
0.00 USD
952.21 K
About Sigyn Therapeutics Inc.
Sector
Industry
CEO
James A. Joyce
Website
Headquarters
San Diego
Founded
2014
ISIN
US82674U2050
FIGI
BBG0099X6C50
Sigyn Therapeutics, Inc. is a development-stage company, which focuses on creating therapeutic solutions that address unmet needs in global health. Its product, Sigyn Therapy, is a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders that are not addressed with approved drug therapies. The company was founded by James A. Joyce and Craig P. Roberts on October 29, 2019 and is headquartered in San Diego, CA.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of SIGY is 3.75 USD — it has increased by 7.14% in the past 24 hours. Watch Sigyn Therapeutics Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Sigyn Therapeutics Inc. stocks are traded under the ticker SIGY.
SIGY stock has risen by 7.14% compared to the previous week, the month change is a 25.00% rise, over the last year Sigyn Therapeutics Inc. has showed a −34.78% decrease.
SIGY reached its all-time high on Oct 18, 2017 with the price of 291,045.30 USD, and its all-time low was 2.08 USD and was reached on Jun 20, 2023. View more price dynamics on SIGY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
SIGY stock is 6.75% volatile and has beta coefficient of 0.03. Track Sigyn Therapeutics Inc. stock price on the chart and check out the list of the most volatile stocks — is Sigyn Therapeutics Inc. there?
Today Sigyn Therapeutics Inc. has the market capitalization of 6.02 M, it has decreased by −12.50% over the last week.
Yes, you can track Sigyn Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Sigyn Therapeutics Inc. is going to release the next earnings report on Nov 12, 2025. Keep track of upcoming events with our Earnings Calendar.
SIGY net income for the last quarter is −1.45 M USD, while the quarter before that showed −668.56 K USD of net income which accounts for −117.06% change. Track more Sigyn Therapeutics Inc. financial stats to get the full picture.
No, SIGY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 26, 2025, the company has 4 employees. See our rating of the largest employees — is Sigyn Therapeutics Inc. on this list?
Like other stocks, SIGY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sigyn Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Sigyn Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Sigyn Therapeutics Inc. stock shows the sell signal. See more of Sigyn Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.